Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × apixaban × 1 year × Clear all

Sponsor

Conditions

Venous Thromboembolism 7 Pulmonary Embolism 3 Neoplasms 3 Venous Thrombosis 2 Multiple Myeloma 2 Hematologic Neoplasms 2 Urinary Bladder Neoplasms 1 Upper Extremity Deep Vein Thrombosis 1 Thromboprophylaxis 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lymphoma 1 Leukemia 1 Intracranial Thrombosis 1 Fibrosis 1 Embolism 1 Catheter-Related Infections 1 Carcinoma, Hepatocellular 1

Interventions

ruxolitinib 8 bomedemstat 3 Specimen Handling 3 Biopsy 3 fludarabine phosphate 2 Whole-Body Irradiation 2 Tacrolimus 2 Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Injections 2 Cyclophosphamide 2 venetoclax 1 veliparib 1 poly ICLC 1 piperine 1 pevonedistat 1 iadademstat 1 givinostat hydrochloride 1 givinostat 1 fludarabine 1 fedratinib 1 demethoxycurcumin 1 decitabine and cedazuridine drug combination 1 anagrelide 1 X-Rays 1 Valganciclovir 1 Topotecan 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡